Skip to main content
Log in

Contrasuppression in autoimmunity

  • Contrasuppression, Symposium
  • Published:
Immunologic Research Aims and scope Submit manuscript

Conclusions

Since our long-term research interest is in immune-mediated interstitial renal disease, these are the models in which we have studied the role of contrasuppression in autoimmunity. Clearly, there is no a priori reason why this should be an immunopathogenic mechanism limited to T cell-mediated tubulointerstitial disease. Indeed, early support for this kind of mechanism was previously obtained in a model of systemic autoimmunity induced by polyclonal B cell activators [25]. There are other autoimmune diseases in which Ts cells have been implicated as tolerogenic mechanisms. These include experimental type I diabets (BB rats [26] and NOD mice [8]), thyroiditis [4], oophoritis [27], and experimental allergic encephalomyelitis [28]. Contrasuppression may well be operative, at least as one process in determining susceptibility to these organ-specific autoimmune lesions. It is important to note that since the effector and regulatory T cells may belong to the same phenotypic subset, identifying a T cell subset which ‘transfers disease’ does not eliminate the possibility that regulatory cells are involved. The investigator must specifically design experiments to look for these complex interactions in order to observe them. Further elucidation of the mechanisms by which Tcs and Ts cells mediate their opposing effects will likely come from comparisons of the protein structure and receptors for their soluble factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Green, D.R.; Flood, P.M.; Gershon, R.K.: Immunoregulatory T-cell pathways. Annu. Rev. Immunol.1: 439–463 (1983).

    Article  PubMed  CAS  Google Scholar 

  2. Neilson, E.G.; McCafferty, E.; Mann, R.; Michaud, L.; Clayman, M.: Tubular antigen-derivatized cells induce a disease-protective, antigen-specific, and idiotype-specific suppressor T cell network restricted by I-J and Igh-V in mice with experimental interstitial nephritis. J. exp. Med.162: 215–230 (1985).

    Article  PubMed  CAS  Google Scholar 

  3. Swierkosz, J.E.; Swanborg, R.J.: Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis. J. Immun.115: 631–633 (1975).

    PubMed  CAS  Google Scholar 

  4. Kong, Y.M.; Okayasu, I.; Giraldo, A.A.; Beisel, K.W.; Sundick, R.S.; Rose, N.R.; David, C.S.; Audibert, I.; Chedid, L.: Tolerance to thyroglobulin by activating suppressor mechanisms. Ann. N.Y. Acad. Sci.392: 191–209 (1982).

    Article  PubMed  CAS  Google Scholar 

  5. Weigle, W.O.: Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv. Immunol.30: 159–273 (1980).

    PubMed  CAS  Google Scholar 

  6. Brondz, B.D.; Abronina, I.F.; Zaiceva, M.B.; Filator, A.V.; Cherunsky, A.V.: Specific suppressor T cells immune to antigens of the H-2 complex: receptors, clonal structure, genetic restriction, and antigenic markers. Immunol. Rev.80: 29–76 (1984).

    Article  PubMed  CAS  Google Scholar 

  7. Lando, Z.; Teitelbaum, D.; Arnon, R.: Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice. Nature, Lond.287: 551–552 (1980).

    Article  CAS  Google Scholar 

  8. Harada, M.; Makino, S.: Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia27: 604–606 (1984).

    Article  PubMed  CAS  Google Scholar 

  9. Kelly, C.J.; Silvers, W.; Neilson, E.G.: Tolerance to parenchymal self: regulatory role of major histocompatibility complex-restricted OX8+ suppressor T cells specific for autologous renal tubular antigen in experimental interstitial nephritis. J. exp. Med.162: 1892–1903 (1985).

    Article  PubMed  CAS  Google Scholar 

  10. Shirai, T.; Hayakawa, K.; Okumura, K.; Tada, T.: Differential cytotoxic effect of natural thymocytotoxic autoantibody of NZB mice on functional subsets of T cells. J. Immun.120: 1924–1929 (1978).

    PubMed  CAS  Google Scholar 

  11. Lyon, M.F.; Hulse, E.V.: An inherited kidney disease of mice resembling human nephronophthisis. J. med. Genet.8: 41–48 (1971).

    Article  PubMed  CAS  Google Scholar 

  12. Neilson, E.G.; McCafferty, E.; Feldman, A.; Clayman, M.D.; Zakheim, B.; Korngold, R.: Spontaneous interstitial nephritis in kdkd mice. I. An experimental model of autoimmune renal disease. J. Immun.133: 2560–2565 (1984).

    PubMed  CAS  Google Scholar 

  13. Fernandes, G.E.; Yunis, E.G.; Miranda, M.; Smith, J.; Good, R.A.: Nutritional inhibition of genetically determined renal disease and autoimmunity with prolongation of life in kdkd mice. Proc. natn. Acad. Sci. USA75: 2888–2892 (1978).

    Article  CAS  Google Scholar 

  14. Kelly, C.J.; Korngold, R.; Mann, R.; Clayman, M.; Haverty, T.; Neilson, E.G.: Spontaneous interstitial nephritis in kdkd mice. II. Characterization of a tubular antigen-specific, H-2K-restricted Lyt-2+ effector T cell that mediates destructive tubulointerstitial injury. J. Immun.136: 526–531 (1986).

    PubMed  CAS  Google Scholar 

  15. Kelly, C.J.; Neilson, E.G.: Contrasuppression in autoimmunity. Abnormal contrasuppression facilitates expression of nephritogenic effector T cells and interstitial nephritis in kdkd mice. J. exp. Med.165: 107–123 (1987).

    Article  PubMed  CAS  Google Scholar 

  16. Lehner, T.; Avery, J.; Jones, T.: Separation and characterization of a subset of human T8+ cells which function as antigen-presenting and contrasuppressor cells. Immunology54: 713–722 (1985).

    PubMed  CAS  Google Scholar 

  17. Neilson, E.G.; Phillips, S.M.: Murine interstitial nephritis. I. Analysis of disease susceptibility and its relationship to pleiomorphic gene products defining both immune-response genes and a restrictive requirement for cytotoxic T cells at H-2K. J. exp. Med.155: 1075–1085 (1982).

    Article  PubMed  CAS  Google Scholar 

  18. Clayman, M.D.; Martinez-Hernandez, A.; Michaud, L.; Alper, R.; Mann, R.; Kefalides, N.A.; Neilson, E.G.: Isolation and characterization of the nephritogenic antigen producing anti-tubular basement membrane disease. J. exp. Med.161: 290–305 (1985).

    Article  PubMed  CAS  Google Scholar 

  19. Neilson, E.G.; McCafferty, E.; Mann, R.; Michaud, L.; Clayman, M.D.: Murine interstitial nephritis. III. The selection of phenotypic and idiotypic (RE-Id) T cell preferences by genes in Igh-1 and H-2K characterizes the cell-mediated potential for disease expression: susceptible mice provide a unique effector T cell repertoire in response to tubular antigen. J. Immun.134: 2375–2382 (1985).

    PubMed  CAS  Google Scholar 

  20. Mann, R.; Kelly, C.J.; Hines, W.H.; Clayman, M.D.; Blanchard, N.; Sun, M.J.; Neilson, E.G.: Effector T cell differentiation in experimental interstitial nephritis. I. The development and modulation of effector lymphocyte maturation by I-J+ regulatory T cells. J. Immun.138: 4200–4208 (1987).

    PubMed  CAS  Google Scholar 

  21. Kelly, C.J.; Zurier, R.; Krakauer, K.A.; Blanchard, N.; Neilson, E.G.: Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis. J. clin. Invest.79: 782–789 (1987).

    Article  PubMed  CAS  Google Scholar 

  22. Neilson, E.G.; McCafferty, E.; Mann, R.; Michaud, L.; Clayman, M.: Tubular antigen-derivatized cells induce a disease-protective, antigen-specific, and idiotype-specific suppressor T cell network restricted by I-J and Igh-V in mice with experimental interstitial nephritis. J. exp. Med.162: 215–230 (1985).

    Article  PubMed  CAS  Google Scholar 

  23. Mann, R.; Zakheim, B.; Clayman, M.; McCafferty, E.; Michaud, L.; Neilson, E.G.: Murine interstitial nephritis. IV. Long-term cultured L3T4+ T cell lines transfer delayed expression of disease as I-A restricted inducers of the effector T cell repertoire. J. Immun.135: 286–293 (1985).

    PubMed  CAS  Google Scholar 

  24. Ptak, W.; Bereta, M.; Marcinkiewicz, J.; Gershon, R.K.; Green, D.R.: Production of antigen-specific contrasuppressor cells and factor and their use in augmentation of cell-mediated immunity. J. Immun.133: 623–628 (1984).

    PubMed  CAS  Google Scholar 

  25. Smith, H.R.; Green, D.R.; Smathers, P.A.; Gershon, R.K.; Raveche, E.S.; Steinberg, A.D.: Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: association with contrasuppressor function. Clin. exp. Immunol.51: 579–586 (1983).

    PubMed  CAS  Google Scholar 

  26. Rossini, A.A.; Faustman, D.; Woda, B.A.; Like, A.A.; Szymanski, I.L.; Mordes, J.P.: Lymphocyte transfusion prevent diabetes in the Bio-Breeding/Worcester (BB/S) rat. J. clin. Invest.74: 39–45 (1984).

    Article  PubMed  CAS  Google Scholar 

  27. Sakaguchi, S.; Takahashi, T.; Nishizuka, Y.: Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-2 cells in normal female mice for the prevention of oophoritis. J. exp. Med.156: 1577–1586 (1982).

    Article  PubMed  CAS  Google Scholar 

  28. Holda, J.H.; Swanborg, R.H.: Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats. Eur. J. Immunol.11: 338–340 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelly, C.J., Neilson, E.G. Contrasuppression in autoimmunity. Immunol Res 7, 56–66 (1988). https://doi.org/10.1007/BF02918154

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02918154

Keywords

Navigation